Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SpectronRx announced the NRC has issued a Materials License for its new Indianapolis, IN headquarters.
read more
Spectrum Pharmaceuticals announced an exclusive licensing agreement with The University of Texas MD Anderson Cancer Center for intellectual property related to certain methods of use of poziotinib.
read more
Spheryx announced the NIH has awarded the company a Phase II SBIR grant to support the modification of their proprietary Total Holographic Characterization technology.
read more
Thursday, December 17, 2015
SPI Pharma, Inc., a fully owned subsidiary of Associated British Foods, and the Functional Additives Division of Asahi Kasei Chemicals have agreed to form an alliance in the field of pharmaceutical additives.
read more
Wednesday, August 04, 2021
SPI Pharma, a leading supplier of solutions to pharmaceutical formulation marketers is pleased to announce a new, exclusive agreement with Azelis Americas, a leading innovation service provider in the specialty chemicals and food ingredients industry...
read more
Thursday, October 01, 2026
SPI Pharma and Colorcon have formed a global partnership to distribute and develop oral solid-dose products. Under the agreement, Colorcon will serve as SPI Pharma’s distribution and innovation partner for its drug delivery systems portfolio.
read more
Tuesday, February 03, 2026
Spruce Biosciences announced the appointments of Daven Mody, Pharm.D., as Senior Vice President of Regulatory and Quality and Bruno Gagnon, B.Pharm., M.Sc., as Senior Vice President, Clinical Development Operations.
read more
SPT Labtech announced an initiative with Thermo Fisher Scientific to co-market solutions that will enable variant detection at a fraction of the cost.
read more
SPT Labtech, a laboratory automation solutions company for the life sciences industry, announced that David Newble has been appointed CEO, stepping up from his previous position as Managing Director. In his new capacity, he takes responsibility for ...
read more
Monday, September 21, 2020
SPT Life Sciences has announced the completion of the acquisition of LBD Life Sciences, a supplier of instrumentation to the drug discovery market in China.
read more
SQI Diagnostics announced a technology development partnership and licensing agreement with the McMaster University Department of Engineering to develop chip technology for use in multi-array disease testing.
read more
SQI Diagnostics announced the sale of a Sqid-X system under the terms of an agreement with IRX Therapeutics.
read more
SRI International (SRI) announced a drug discovery research collaboration with Sanofi. By leveraging SRI’s SynFini™ platform, an artificial intelligence (AI)-guided, automated synthetic-chemistry system, the collaboration will discover and develop ...
read more
SRI International announced a research agreement with Ionis, combining SRI's proprietary FOX Three Molecular Guidance cellular targeting system with Ionis' proprietary antisense drug-discovery platform.
read more
SRI International has been awarded a contract of up to $19.8 million from the National Cancer Institute (NCI) PREVENT Cancer Preclinical Drug Development Program to support the development of potential cancer preventive agents or vaccines.
read more